BBII Message Board - Msg: 8545193

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BBII

BBII 0.0550

+37.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Barry Shore who wrote (9)	3/26/1999 12:57:00 PM
From: DRRISK	Read Replies (1) of 28

Thread, Imho this is a great company that is a buy due to its potential as well as its core business. They are the gold standard for controls in the infectious disease diagnostic market. Their research effort could be huge on the upside. They have a technology in pressure cycling that is applicable in nucleic acid extraction and plasma inactivation which is patented and proprietary. The drug discovery program is early but could yield considerable value. They are finally breaking out of their no volume blues and this is a company that has no where to go but up IMHO. Debt is only 3 million no convertible vehicles in place and they have earnings which is always a plus. Small float 4.8 million with large insider ownership. Grew revenues in 97-98 at 17% with projection for 17%+ in 1999. Recent National Securities put buy on stk. FWIW and IMHO. DrRisk I like this company

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next